GlassScriptPhysician profile
R Phillip Dellinger
NPI 1336246453
$74,062.76
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,114 · 2020: $5,010 · 2021: $21K · 2022: $3,760 · 2023: $11K · 2024: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Travel and Lodging: $13K · Honoraria: $4,280 · Food and Beverage: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,841.25 |
| Travel and Lodging | $12,986.27 |
| Honoraria | $4,280.00 |
| Food and Beverage | $173.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $33,536.88 | 2020-2024 | |
| Becton, Dickinson and Company | $9,620.21 | 2023 | |
| Merck Sharp & Dohme LLC | $9,239.42 | 2019-2021 | |
| Bard Access Systems, INC. | $4,681.25 | 2024 | |
| Pfizer INC. | $4,500.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $4,275.00 | 2021 | |
| Philips North America LLC | $3,760.00 | 2022 | |
| Roche Diagnostics International LTD | $3,000.00 | 2021 | |
| Xellia Pharmaceuticals | $1,450.00 | 2023 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw R Phillip Dellinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.